# Intellia Therapeutics, Inc.: Form 8-K, filed Aug 7, 2025

- Company: [Intellia Therapeutics, Inc.](/companies/ntla.md) (CIK 1652130)
- Form: 8-K
- Filed: 2025-08-07
- Accepted by EDGAR: Aug 7, 2025, 07:45 ET
- Period: 2025-08-07
- Accession: 0000950170-25-104574
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1652130/000095017025104574/ntla-20250807.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1652130/000095017025104574/

## Items reported

- Item 2.02: Results of operations
- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1652130/000095017025104574/ntla-20250807.htm

Filed Aug 7, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-104574. Last ingested by Listed: Nov 2, 2026, 17:17 ET. No prices; not investment advice.